Financials in USD. Standardized financial statements.
A compact view of how P3 Health Partners Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.46B | $1.50B | $1.27B | $1.05B | $637.36M | $491.06M | $145.48M | $87.70M |
| Revenue Growth? | -2.8% | +18.5% | +20.7% | +64.7% | +29.8% | +237.5% | +65.9% | 0.0% |
| Cost of Revenue? | $1.60B | $0 | $0 | $0 | $668.07M | $0 | $0 | $0 |
| Gross Profit? | -$144.32M | $1.50B | $1.27B | $1.05B | -$30.70M | $491.06M | $145.48M | $87.70M |
| Gross Margin? | -9.9% | +100.0% | +100.0% | +100.0% | -4.8% | +100.0% | +100.0% | +100.0% |
| Operating Expenses? | $125.98M | $1.82B | $1.43B | $2.61B | $157.24M | $519.65M | $185.02M | $137.41M |
| Operating Income? | -$270.30M | -$320.66M | -$167.93M | -$1.56B | -$187.95M | -$28.59M | -$39.54M | -$49.71M |
| EBITDA? | -$186.14M | -$197.76M | -$81.07M | -$1.46B | -$184.61M | -$28.08M | -$39.04M | -$49.37M |
| Income Before Tax | -$321.06M | -$305.99M | -$183.73M | -$1.56B | -$204.34M | -$31.41M | -$41.97M | -$49.77M |
| Income Tax Expense | $2.02M | $4.39M | $2.69M | $1.86M | $0 | $0 | $0 | $0 |
| Net Income? | -$147.95M | -$135.85M | -$57.77M | -$270.13M | -$156.48M | -$31.41M | -$41.97M | -$43.80M |
| EPS? | $-45.26 | $-46.79 | $-30.44 | $-324.84 | $-188.17 | $-39.73 | $-44.10 | $-92.04 |
| Diluted EPS? | $-45.26 | $-54.06 | $-30.44 | $-324.84 | $-188.17 | $-39.73 | $-44.10 | $-92.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality